NO157048C - Fremgangsmaate til fremstilling av en tablett. - Google Patents

Fremgangsmaate til fremstilling av en tablett.

Info

Publication number
NO157048C
NO157048C NO800847A NO800847A NO157048C NO 157048 C NO157048 C NO 157048C NO 800847 A NO800847 A NO 800847A NO 800847 A NO800847 A NO 800847A NO 157048 C NO157048 C NO 157048C
Authority
NO
Norway
Prior art keywords
tablet
procedure
preparation
Prior art date
Application number
NO800847A
Other languages
English (en)
Norwegian (no)
Other versions
NO157048B (no
NO800847L (no
Inventor
Michael K Ullman
Stephen T David
Claude E Gallian
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26698095&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO157048(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/024,139 external-priority patent/US4215104A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NO800847L publication Critical patent/NO800847L/no
Publication of NO157048B publication Critical patent/NO157048B/no
Publication of NO157048C publication Critical patent/NO157048C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
NO800847A 1979-03-26 1980-03-25 Fremgangsmaate til fremstilling av en tablett. NO157048C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/024,139 US4215104A (en) 1979-03-26 1979-03-26 Multi-fractionable tablet structure
US06/121,615 US4258027A (en) 1979-03-26 1980-02-14 Multi-fractionable tablet structure

Publications (3)

Publication Number Publication Date
NO800847L NO800847L (no) 1980-09-29
NO157048B NO157048B (no) 1987-10-05
NO157048C true NO157048C (no) 1988-01-27

Family

ID=26698095

Family Applications (1)

Application Number Title Priority Date Filing Date
NO800847A NO157048C (no) 1979-03-26 1980-03-25 Fremgangsmaate til fremstilling av en tablett.

Country Status (26)

Country Link
US (1) US4258027A (da)
AT (1) AT372853B (da)
AU (1) AU533115B2 (da)
CA (1) CA1133393A (da)
CH (1) CH644515A5 (da)
CY (1) CY1311A (da)
DE (1) DE3011680C2 (da)
DK (1) DK155566C (da)
ES (1) ES263036Y (da)
FI (1) FI800884A7 (da)
FR (1) FR2452284A1 (da)
GB (1) GB2047095B (da)
GR (1) GR67751B (da)
HK (1) HK92985A (da)
HU (1) HU191022B (da)
IE (1) IE49579B1 (da)
IL (1) IL59697A (da)
IT (1) IT1143959B (da)
KE (1) KE3571A (da)
LU (1) LU82297A1 (da)
MY (1) MY8600287A (da)
NL (1) NL189175C (da)
NO (1) NO157048C (da)
PH (1) PH16802A (da)
SE (1) SE446061B (da)
YU (1) YU42100B (da)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4353887A (en) * 1979-08-16 1982-10-12 Ciba-Geigy Corporation Divisible tablet having controlled and delayed release of the active substance
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
ZA813205B (en) * 1980-12-05 1983-03-30 Smith Kline French Lab Dosage units
US4465660A (en) * 1981-04-01 1984-08-14 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
DE3314003A1 (de) * 1983-04-18 1984-10-18 Boehringer Ingelheim KG, 6507 Ingelheim Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
DE3610878A1 (de) * 1986-04-01 1987-10-08 Boehringer Ingelheim Kg Formlinge aus pellets
US4793493A (en) * 1986-09-18 1988-12-27 Makiej Jr Walter J Multidose capsules
USD303160S (en) 1986-09-26 1989-08-29 Smith Kline & French Laboratories, Limited Pharmaceutical tablet
US4735805A (en) * 1987-03-11 1988-04-05 The Upjohn Company Bisectable drug tablet
USD310579S (en) 1989-04-28 1990-09-11 The Upjohn Company Triscored drug tablet
US5009896A (en) * 1989-10-04 1991-04-23 Akzo N.V. Multi-fractionable tablet structure
US5061494A (en) * 1990-06-14 1991-10-29 The Upjohn Comany Tri-scored drug tablet
GB9101502D0 (en) * 1991-01-23 1991-03-06 Controlled Therapeutics Sct Controlled release compositions
JP2577080Y2 (ja) * 1991-09-10 1998-07-23 武田薬品工業株式会社 分割自在固形体
DE4342146C1 (de) * 1993-12-10 1995-07-06 Notter Gmbh Ringtablette
USD373187S (en) 1994-03-09 1996-08-27 The Boots Company Plc Pharmaceutical tablet
DE9415022U1 (de) * 1994-09-15 1994-11-17 Azupharma GmbH, 70839 Gerlingen Tablettenartiger Körper mit Bruchkerbe
US5756124A (en) * 1995-08-07 1998-05-26 Invamed, Inc. Multi-scored pharmaceutical tablets
GB9624563D0 (en) * 1996-11-27 1997-01-15 Smithkline Beecham Plc Product
DE19837684A1 (de) * 1998-08-19 2000-02-24 Knoll Ag Exakt teilbare Tablette
GB9914620D0 (en) * 1999-06-23 1999-08-25 Eu Pharma Ltd Divisible tablets
USD440650S1 (en) 2000-01-27 2001-04-17 Watson Pharmaceuticals, Inc. Tablet
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
TW200502000A (en) * 2003-03-28 2005-01-16 Kyowa Hakko Kogyo Kk Dividing tablet
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
FR2859632B1 (fr) * 2003-09-15 2005-11-18 Arrow Generiques Comprime multisecable a observance amelioree.
US8157788B2 (en) * 2003-11-06 2012-04-17 Paolo L. Manfredi Multi-site drug delivery platform
CA2565029C (en) 2004-05-21 2013-09-03 Lawrence Solomon Immediate release pharmaceutical tablets with height greater than width
US7838031B2 (en) * 2004-05-21 2010-11-23 Lawrence Solomon Method of administering a partial dose using a segmented pharmaceutical tablet
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
JP5059611B2 (ja) * 2005-08-18 2012-10-24 帝人ファーマ株式会社 正確な用量分割機能を有する製剤
WO2007121356A2 (en) * 2006-04-13 2007-10-25 Accu-Break Technologies Method of treatment with predictably breakable pharmaceutical tablets
US20080264430A2 (en) * 2006-11-21 2008-10-30 Edmund Roschak Methods and devices for accessing the heart
US7985419B1 (en) 2006-12-22 2011-07-26 Watson Laboratories, Inc. Divisible tablet and associated methods
USD586397S1 (en) * 2007-09-06 2009-02-10 Acme United Corporation Ribbed eraser
CA2713128C (en) 2008-01-25 2016-04-05 Gruenenthal Gmbh Pharmaceutical dosage form
BRPI0912014A2 (pt) 2008-05-09 2019-03-06 Grünenthal GmbH processo para a preparação de uma formulação em pó intermediária e uma forma de dosagem sólida final sob uso de uma etapa de congelamento por atomização
CN102573805A (zh) 2009-07-22 2012-07-11 格吕伦塔尔有限公司 热熔挤出的控制释放剂型
RU2015138422A (ru) 2009-07-22 2018-12-25 Грюненталь Гмбх Стабильная при окислении, прочная на излом лекарственная форма
NZ607392A (en) 2010-09-02 2015-03-27 Gruenenthal Chemie Tamper resistant dosage form comprising inorganic salt
BR112013005234A2 (pt) 2010-09-02 2016-05-03 Gruenenthal Gmbh forma de dosagem resistente à violação compreendendo um polímero aniônico.
US8383135B2 (en) * 2010-12-03 2013-02-26 Richard C. Fuisz Solid dosage form that promotes reliable oral, esophageal and GI transit
PE20141638A1 (es) 2011-07-29 2014-11-22 Gruenenthal Chemie Tableta a prueba de manipulacion que proporciona liberacion de farmaco inmediato
RS56527B1 (sr) 2011-07-29 2018-02-28 Gruenenthal Gmbh Tableta za trenutno oslobađanje leka rezistentna na zloupotrebu
MX356421B (es) 2012-02-28 2018-05-29 Gruenenthal Gmbh Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico.
DK2838512T3 (da) 2012-04-18 2018-11-19 Gruenenthal Gmbh Manipulationssikret og dosisdumpingsikret farmaceutisk doseringsform
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
JP6445537B2 (ja) 2013-05-29 2018-12-26 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング １個または複数の粒子を含有する改変防止（ｔａｍｐｅｒ−ｒｅｓｉｓｔａｎｔ）剤形
AR096439A1 (es) 2013-05-29 2015-12-30 Gruenenthal Gmbh Forma de dosificación resistente al uso indebido que contiene una o más partículas
US10624862B2 (en) 2013-07-12 2020-04-21 Grünenthal GmbH Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
AU2014356581C1 (en) 2013-11-26 2020-05-28 Grunenthal Gmbh Preparation of a powdery pharmaceutical composition by means of cryo-milling
USD723155S1 (en) 2014-02-11 2015-02-24 Pharmavite Llc Tablet
MX2016014738A (es) 2014-05-12 2017-03-06 Gruenenthal Gmbh Formulacion en capsula de liberacion inmediata resistente a alteraciones que comprende tapentadol.
MX2016015417A (es) 2014-05-26 2017-02-22 Gruenenthal Gmbh Multiparticulas protegidas contra vertido de dosis etanolico.
JP2018517676A (ja) 2015-04-24 2018-07-05 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 即時放出および溶媒抽出に対する耐性を有する改変防止製剤
BR112018001609A2 (en) 2015-08-21 2018-09-18 Aprecia Pharmaceuticals LLC system and assembly of three-dimensional printing equipment
AU2016319203A1 (en) 2015-09-10 2018-02-22 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
DE102016119675A1 (de) 2016-10-14 2018-04-19 Ritter Pharma-Technik Gmbh Tablette mit Bruchwinkel und senkrecht zur Pressrichtung eingebrachter Teilungskerbe
USD827721S1 (en) * 2017-03-15 2018-09-04 Click-Block Corporation Triangular tile magnetic toy
USD906294S1 (en) * 2019-01-28 2020-12-29 Compal Electronics, Inc. Set of earbuds
JP1637714S (da) * 2019-02-08 2019-07-29
JP1640288S (da) * 2019-02-08 2019-09-02
JP1637715S (da) * 2019-02-08 2019-07-29
US20210378968A1 (en) * 2020-05-28 2021-12-09 Johnson & Johnson Consumer Inc. Multi-cavity customizable dosage forms

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US94644A (en) * 1869-09-07 Improvement in horse hat-forks
FR438385A (fr) * 1911-01-02 1912-05-15 Fernande Barry Le Grand Bijoux et parures en bonbons et pates de fruits ou toute autre pate
US1836604A (en) * 1929-06-01 1931-12-15 Simon M Meyer Sugar unit
US2052376A (en) * 1933-05-18 1936-08-25 Edgar G Zellers Insoluble pill or tablet for internal medicinal uses
USD91644S (en) 1933-12-22 1934-03-06 Alex Blackstone Design for a proprietary medicine bar
NL109293C (da) 1955-12-22
DE1200790B (de) * 1961-12-06 1965-09-16 Thomas L Cooper Zerlegbare Tablette
GB993291A (en) * 1961-12-06 1965-05-26 Thomas Lee Cooper Tablets, pills, pellets and the like
US3336200A (en) * 1963-05-28 1967-08-15 Warner Lambert Pharmaceutical Tablet structure
USD202467S (en) 1963-10-07 1965-10-05 Jacques Guilmot Pharmaceutical tablets
USD201497S (en) 1964-09-28 1965-06-29 Warner Lambert Co Tablet
CH502891A (de) * 1967-11-21 1971-02-15 Ciba Geigy Ag Technische, gekerbte Tablette
US3723614A (en) * 1971-01-06 1973-03-27 Ciba Geigy Ag Maltese-cross scored tablet
GB1368574A (en) * 1971-02-12 1974-10-02 Ives Lab Inc Divisible tablet
GB1387643A (en) * 1971-03-16 1975-03-19 Ives Lab Inc Divisible tablet
US3883647A (en) * 1972-12-06 1975-05-13 Ives Lab Tablet formulation

Also Published As

Publication number Publication date
SE8002303L (sv) 1980-09-27
DK128580A (da) 1980-09-27
AT372853B (de) 1983-11-25
NL8001700A (nl) 1980-09-30
DE3011680A1 (de) 1980-10-09
KE3571A (en) 1985-11-08
HK92985A (en) 1985-11-29
SE446061B (sv) 1986-08-11
DK155566C (da) 1989-09-11
NO157048B (no) 1987-10-05
PH16802A (en) 1984-03-01
FI800884A7 (fi) 1981-01-01
GB2047095A (en) 1980-11-26
ATA160880A (de) 1983-04-15
NO800847L (no) 1980-09-29
YU42100B (en) 1988-04-30
NL189175B (nl) 1992-09-01
GB2047095B (en) 1983-08-24
IL59697A (en) 1983-11-30
CA1133393A (en) 1982-10-12
LU82297A1 (fr) 1980-10-08
AU5647480A (en) 1980-10-02
FR2452284B1 (da) 1983-06-17
IE800612L (en) 1980-09-26
ES263036Y (es) 1984-04-01
HU191022B (en) 1986-12-28
NL189175C (nl) 1993-02-01
FR2452284A1 (fr) 1980-10-24
YU77280A (en) 1983-04-30
IL59697A0 (en) 1980-06-30
ES263036U (es) 1982-11-01
IE49579B1 (en) 1985-10-30
DK155566B (da) 1989-04-24
GR67751B (da) 1981-09-18
US4258027A (en) 1981-03-24
IT1143959B (it) 1986-10-29
IT8048241A0 (it) 1980-03-24
DE3011680C2 (de) 1997-04-30
MY8600287A (en) 1986-12-31
CY1311A (en) 1986-03-28
AU533115B2 (en) 1983-11-03
CH644515A5 (de) 1984-08-15

Similar Documents

Publication Publication Date Title
NO149389C (no) Fremgangsmaate til fremstilling av 4,1`,6`-triklor-4,1`,6`-trideoksy-galaktosukrose
NO822722L (no) Fremgangsmaate til fremstilling av benzazepin-2-oner.
FI800884A7 (fi) Moninkertaisesti rikottava tablettirakenne.
NO147751C (no) Fremgangsmaate til fremstilling av 4-hydroksypyrrolidin-2-on-amider.
NO803591L (no) Fremgangsmaate for fremstilling av fiskemel.
NO770286L (no) Fremgangsm}te til fremstilling av dinatriumkromglycat.
NO145837C (no) Fremgangsmaate for fremstilling av en voks-flegmatisk spengstoffblanding
NO803313L (no) Tablett.
NO155477C (no) Fremgangsmaate ved fremstilling av et konsentrert protrombinkompleks.
NO770366L (no) Fremgangsm}te for fremstilling av meta-aryloksy-benzaldehyder.
NO160991C (no) Fremgangsmaate til fremstilling av en hydrolyserbar titanylsulfatopploesning.
NO145158C (no) Fremgangsmaate til fremstilling av gipsprodukter.
NO156210C (no) Fremgangsmaate til fremstilling av monacolin k derivater.
NO771159L (no) Fremgangsm}te ved fremstilling av titantetraklorid.
NO153978C (no) Fremgangsmaate til fremstilling av naaletrecellulose for kjemisk videreforarbeiding samt for spesialpapir.
NO152892C (no) Fremgangsmaate til fremstilling av en vandig mavesyre-noeytraliserende suspensjon.
NO153853C (no) Fremgangsmaate for fremstilling av 17beta-hydroksy-17alfa-pregn-5-en-21-karboksylsyre-gamma-laktoner.
NO152645C (no) Fremgangsmaate for fremstilling av klordioksyd.
NO801142L (no) Fremgangsmaate til fremstilling av klordioksyd.
NO149630C (no) Analogifremgangsmaate til fremstilling av anti-psoriatiske 1,8-dihydroksy-10-acyl-9-antroner
NO781489L (no) Fremgangsmaate til fremstilling av 1,2-dikloretan
NO800185L (no) Fremgangsmaate for fremstilling av et disubstituert (n-cyanimido)karbonat.
NO791458L (no) Fremgangsmaate til fremstilling av 1,2-dikloretan
NO152840C (no) Fremgangsmaate for fremstilling av dibenzyletere.
NO160992C (no) Fremgangsmaate til fremstilling av en hydrolyserbar titanylsulfatopploesning.